Articles published by Weave Bio

Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities

Today 9:00 EDT

From Weave Bio

Via Business Wire

Weave Bio Expands Strategic Advisory Board with Two Former FDA Leaders

July 16, 2026

From Weave Bio

Via Business Wire

Weave Bio Enables Global Submissions From a Single Source of Truth

June 15, 2026

From Weave Bio

Via Business Wire

Weave Bio Launches NDA Workflow Designed in Partnership with Parexel; Extending AI-Native Platform Coverage Across the Full Regulatory Lifecycle

April 29, 2026

From Weave Bio

Via Business Wire

Weave Bio Establishes Inaugural Strategic Advisory Board to Shape the Future of AI-Driven Regulatory Science

March 25, 2026

From Weave Bio

Via Business Wire

Weave Bio Launches HAQ Manager, Extending AI-Native Regulatory Automation into Critical Review Phase

November 06, 2025

From Weave Bio

Via Business Wire

Weave Bio Secures $20M Series A Funding to Enhance Its AI-Native Regulatory Platform

October 16, 2025

From Weave Bio

Via Business Wire

Weave Bio Earns the 2024 “BioTech AI Innovation Of The Year” Award

November 19, 2024

From Weave Bio

Via Business Wire

Weave Bio Announces $10M in New Funding and Launch of Its AI-Powered Platform to Streamline Drafting, Reviewing & Submitting Regulatory Documents in Drug Development

May 30, 2024

From Weave Bio

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.